Subscribe to RSS

DOI: 10.1055/s-0043-1771275
Adolescent and Young Adults with Gastric Cancer (AYA-GC)—The Dilemma of an Under-Represented Group: A Multi-Institutional Analysis from the Indian Subcontinent
Funding The authors are thankful to Biotechnology Industry Research Assistance Council (BIRAC) through the National Biopharma Mission to provide funding for the research.
Abstract


Gastric cancer (GC) is often ignored at a young age, which frequently leads to tragic consequences. The worldwide incidence of GC is increasing at a young age. In view of the limited Indian publication, we sought to characterize clinicopathological parameters and risk factors in the adolescents and young adults (AYA) population. Retrospective data from six centers (which are part of the Network of Oncology Clinical Trials in India) from 2015 to 2020 were collected from patient (18–39 years of age) records. This study was approved by the institutional ethical committee of individual centers. All statistical analyses were performed using Microsoft Excel and SPSS (Version 20). Data interpretation along with the analysis of obtained results was carried out using the following tests: Qualitative data was expressed in terms of frequency/percentage. One-hundred fifty-two AYA GC patients were enrolled. The 31 to 39 years age group was most affected in which 76.3% were females. The majority of patients were nonalcoholic (93.4%), nonsmokers (98.0%), and without a family history (98.0%). The most common (MC) presenting symptom was abdominal pain (67.1%). MC site was antrum (48%). Among esophagogastric junction cancers, the majority were type I and II Siewert classifications (77% [20/26] patients in cardia), MC histology—signet ring cell (67.1%) followed by diffuse-type (65.1%). Most were poorly differentiated (65.1%) and were diagnosed at an advanced stage (III & IV= 54.6%). This is one of our country's first large multicenter studies on GC in the AYA population. There was a higher female prevalence, aggressive tumor behavior and the majority of patients were diagnosed at a more advanced stage. The majority were nonsmokers with a negative family history. Awareness among general people, researchers, clinicians, and policymakers must be improved to better the loss of life years in the younger population.
Keywords
adolescent and young adults - gastric cancer - multi-institutional - incidence - prevalence - Network of Oncology Clinical Trials in IndiaEthical Approval
The study was approved by the Institutional Ethics Committee (vide IMS.SH/SOA/2021/097 letter dated 07.07.2021). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Publication History
Article published online:
21 July 2023
© 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Li J, Kuang XH, Zhang Y, Hu DM, Liu K. Global burden of gastric cancer in adolescents and young adults: estimates from GLOBOCAN 2020. Public Health 2022; 210: 58-64
- 2 De B, Rhome R, Jairam V. et al. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer 2018; 21 (06) 889-899
- 3 Li J. Gastric cancer in young adults: a different clinical entity from carcinogenesis to prognosis. Gastroenterol Res Pract 2020; 2020: 9512707
- 4 Magrath I, Epelman S. Cancer in adolescents and young adults in countries with limited resources. Curr Oncol Rep 2013; 15 (04) 332-346
- 5 Wong MCS, Huang J, Chan PSF. et al. Global incidence and mortality of gastric cancer, 1980-2018. JAMA Netw Open 2021; 4 (07) e2118457
- 6 Dhobi MA, Wani KA, Parray FQ. et al. Gastric cancer in young patients. Int J Surg Oncol 2013; 2013: 981654
- 7 Maheshwari U, Sharma M, Goel V. et al. Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian J Oncol 2022; 08 (03) 111-118
- 8 Al-Refaie WB, Hu CY, Pisters PWT, Chang GJ. Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol 2011; 18 (10) 2800-2807
- 9 Zhao D, Klempner SJ, Chao J. Progress and challenges in HER2-positive gastroesophageal adenocarcinoma. J Hematol Oncol 2019; 12 (01) 50
- 10 Lee J, Lee MA, Kim IH, Roh SY. Clinical characteristics of young-age onset gastric cancer in Korea. BMC Gastroenterol 2016; 16 (01) 110
- 11 Liang YX, Deng JY, Guo HH. et al. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years. World J Gastroenterol 2013; 19 (39) 6568-6578
- 12 Saidi S. P-327 gastric cancer in elderly patients. Ann Oncol 2020; 31: S196
- 13 al Otaibi M, al Barak J, al Abbad J, Akbar A. Differences in presentation and outcomes among young and old patients with gastric cancer. Ann Oncol 2018; 29: viii234
- 14 Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32 (01) 3-11